Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancers|November 13, 2020
Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled CohortBogyeong Han, Sehui Kim, Jiwon Koh, et al.Blood Advances|September 18, 2024
Increased CCL2/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC/BCL2 double-expressor DLBCLSehui Kim, Hyein Jeong, Hyun Kyung Ahn, et al.BMC Cancer|November 2, 2022
High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltrationSehui Kim, Jaemoon Koh, Seung Geun Song, et al.The American Journal of Surgical Pathology|January 4, 2022
Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene SequencingJeemin Yim, Jiwon Koh, Sehui Kim, et al.Oncoimmunology|August 21, 2019
High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous systemSehui Kim, Soo Jeong Nam, Changhee Park, et al.Medicine|September 9, 2025
Case report of extranodal NK/T-cell lymphoma mimicking Behcet syndromeSongyi Park, Jeemin Yim, Hye Eun Park, et al.Diagnostic Pathology|September 22, 2020
Clinicopathological findings of pediatric NTRK fusion mesenchymal tumorsJeongwan Kang, Jin Woo Park, Jae-Kyung Won, et al.Blood Advances|January 16, 2026
Distribution and prognostic impact of LymphGen subtypes in Korean diffuse large B-cell lymphoma using clinical NGS panelJeemin Yim, Sungyoung Lee, Sehui Kim, et al.European Journal of Cancer (Oxford, England : 1990)|August 15, 2022
TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancerJaemoon Koh, Sehui Kim, Yeon Duk Woo, et al.Journal for Immunotherapy of Cancer|March 6, 2025
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancerHyein Jeong, Jaemoon Koh, Sehui Kim, et al.Pageof 2